JOINT CORP Reports Earnings Results for FY2023 Q2, Ending June 30 2023
October 21, 2023
🌥️Earnings Overview
On September 13 2023, JOINT CORP ($NASDAQ:JYNT) released its earnings report for the second quarter of FY2023, which ended on June 30 2023. The company reported total revenue of USD 29.3 million, a 17.0% year over year increase. However, net income for the quarter was reported as USD -0.19 million, a decline from the USD 0.34 million reported in the same quarter in the previous fiscal year.
Stock Price
On Wednesday, JOINT CORP reported its earnings results for the second quarter of fiscal year 2023, which ended June 30, 2023. Despite posting strong profits for the quarter, JOINT CORP’s stock opened at $9.5 and closed at $9.4, down 1.8% from its previous closing price of 9.5. The decrease in the stock price was attributed to a weaker than expected outlook for the company’s future prospects. Despite this, analysts remain optimistic that JOINT CORP will continue to perform well in the upcoming quarters. Despite the increase, analysts were concerned about the company’s margins, which were slightly lower than expected.
Overall, JOINT CORP had a successful quarter compared to the same period a year ago and is optimistic about its future prospects. The company is well-positioned to capitalize on current trends and is continuing to invest in its operations and resources in order to remain competitive in the industry. As such, analysts remain optimistic that JOINT CORP will be able to continue posting strong results for the remainder of the fiscal year. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Joint Corp. More…
| Total Revenues | Net Income | Net Margin |
| 112.02 | 3.17 | 3.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Joint Corp. More…
| Operations | Investing | Financing |
| 17.11 | -13.14 | 0.44 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Joint Corp. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 99.35 | 63.74 | 2.42 |
Key Ratios Snapshot
Some of the financial key ratios for Joint Corp are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 28.5% | -24.5% | 1.1% |
| FCF Margin | ROE | ROA |
| 10.2% | 2.3% | 0.8% |
Analysis
At GoodWhale, we have analysed JOINT CORP‘s financials and we’ve determined that it is a medium risk investment in terms of financial and business aspects. We have identified three risk warnings in the income sheet, balance sheet, and cashflow statement. For further detailed analysis, please register on goodwhale.com. We have taken multiple different factors into account when assessing the financial soundness of JOINT CORP. This includes analyzing the company’s income sheet, balance sheet, and cashflow statement. Upon analysis, we have detected 3 risk warnings which could potentially harm the financial stability of the company. For a more thorough assessment, we suggest registering with goodwhale.com. Our detailed analysis will provide you with more detailed insights into JOINT CORP’s financial situation and any potential risks associated with investing in this company. More…
Peers
The Joint Corp is a publicly-traded company that owns and operates chiropractic clinics in the United States. The company was founded in 1999 and is headquartered in Scottsdale, Arizona. The Joint Corp’s main competitors are Ethema Health Corp, PT Sejahteraraya Anugrahjaya Tbk, and Ensign Group Inc.
– Ethema Health Corp ($OTCPK:GRST)
Ethema Health Corp is a healthcare company with a focus on providing services to the underserved population. The company has a market cap of 1.86M as of 2022 and a Return on Equity of -25.22%. The company’s mission is to provide quality healthcare to those who need it the most. Ethema Health Corp has a strong commitment to social responsibility and provides services to the community through its clinics, mobile units, and outreach programs. The company has a long history of serving the underserved and is dedicated to providing quality care to its patients.
– PT Sejahteraraya Anugrahjaya Tbk ($IDX:SRAJ)
Pt Sejahteraraya Anugrahjaya Tbk is an Indonesian company that focuses on the construction and engineering sector. The company has a market cap of 1.54T as of 2022 and a return on equity of 2.06%. The company has been involved in various large-scale construction projects in Indonesia, such as the construction of the Jakarta-Cikampek Toll Road and the Trans-Java Toll Road.
– Ensign Group Inc ($NASDAQ:ENSG)
The Ensign Group is a holding company for a number of healthcare service providers. Its operations are primarily in the United States, with a focus on skilled nursing and assisted living facilities. The company also provides home health, hospice, and senior living services.
Ensign has a market cap of 4.77B as of 2022. Its return on equity is 19.3%. Ensign’s focus on skilled nursing and assisted living facilities gives it a strong position in the healthcare services industry. The company’s size and scale give it the ability to provide a wide range of services to its customers. Ensign’s focus on quality care and customer service is evident in its high return on equity. Ensign is a well-run company that is well-positioned to continue growing in the healthcare services industry.
Summary
Investors should take note of JOINT CORP‘s second quarter results for FY2023, which ended on June 30, 2023. Total revenue increased by 17.0% year over year, reaching USD 29.3 million. Despite this, net income was a loss of USD -0.19 million, a decrease from the 0.34 million reported in the same period last year.
This could be a sign of potential trouble for investors, as the company may not be able to sustain its growth without further investment. Investors should conduct further research and analysis before making a decision to invest in JOINT CORP.
Related Posts
Recent Posts
